• WCG’s eCOA portfolio and imaging analysis technology from NeuroRx are now part of Clario!

menu-close-icon
Your using an unsupported browser. Please update to a modern browser for a better experience.
Skip to content
Clario Clario
  • Solutions
    • Study Endpoints
        • Cardiac safety and efficacy endpoint solutions for all phases, anywhere in the world.

        • Collect continuous ECG data in site-based or hybrid trials with our flexible solutions and patient-friendly devices.

        • Collect and centrally analyze accurate, consistent, quality blood pressure data from site-based to hybrid trials.

        • Monitor every heartbeat with precision to assess safety and efficacy throughout your site-based or hybrid clinical trial.

        • Fulfill your ICH E14 requirement early, minimize risk and potentially reduce costs throughout your trial.

        • Leverage our key opinion leaders to understand the complex regulatory landscape while minimizing risk with confidence.

        • Make your clinical trials easier, faster, more engaging and accessible to all.

        • Enjoy flexible, fast and confidential site assessments at home.

        • Enhance your ePRO data with photo and audio capture.

        • Accelerate your clinical trial setup with Clario’s pre-validated and configured eCOA assessments.

        • Improve data accuracy and reduce variability in scoring with Clario’s training solutions.

        • Your trusted partner for the richest eCOA endpoint data in your clinical trial.

        • Monitor Suicide Ideation and Behavior (SIB) in clinical trials effectively with Clario’s suicide assessment tool, eC-SSRS.

        • Accelerate drug development and reduce risk with Clario’s comprehensive medical imaging core lab services.

        • The Clario team includes medical imaging experts and globally recognized key opinion leaders (KOLs) representing multiple disciplines.

        • Clario’s Image Redact AI automatically redacts sensitive patient identifiers from videos, photos and PDFs.

        • Secure accurate results, streamline your processes, and meet your unique needs with our imaging platform.

        • Leverage our full range of medical imaging and diagnostic imaging modalities, including CT Scans, Endoscopy, MRIs, and more.

        • Securely collect, store, and share de-identified images for compliance with 21 CFR Part 11 and EU GDPR standards.

        • Clario's complete solution for measuring objective digital endpoints of mobility with wearable sensor technology.

        • The Opal V2R® is a research grade wearable sensor that delivers meaningful outcomes and richer insights.

        • Explore more than 750 scientific publications that reflect the technical and clinical applications of Clario’s Opal® System.

        • Everything you need for high quality, low variability pulmonary function data and high patient compliance for clinical trials.

        • Centralized, on-site pulmonary function testing for clinical trials.

        • Remote spirometry testing for respiratory clinical trials.

        • Assess cough frequency, cough severity and other lung sounds such as crackles or rhonchi for clinical trials.

        • Assess the capacity of the lungs for effective gas transfer.

        • Advanced, cloud-native technologies and clinical trial software to screen, clean, QC and assess complicated data.

        • Collect, centralize and manage participant screening and eligibility data with customized workflows.

        • Boost stakeholder insights with business intelligence (BI) tools, analytics for endpoint and safety risks, and data exchange solutions.

        • Securely collect, store and share compliant images in the cloud to keep clinical trial sponsors and labs informed.

    • Segments
    • Study Phases
    • Technology
  • Therapeutic Areas
    • Cardiovascular & Metabolic Icon RGBCardiovascular & Metabolic
    • Dermatology Icon RGBDermatology
    • Type 2 Diabetes and Obesity iconDiabetes and Obesity
    • Gastroenterology Icon RGBGastroenterology
    • Hepatology Icon RGBHepatology
    • Infectious Disease Icon RGBInfectious Diseases
    • Muskoskeletal Icon RGBMusculoskeletal
    • Neuroscience Icon RGBNeuroscience
      • Neuroscience Indications
    • Oncology Icon RGBOncology
    • Ophthalmology Icon RGBOphthalmology
    • Respiratory Solutions IconRespiratory
  • Resources
    • Blog Articles
    • Case Studies
    • Downloads
    • Events
    • External Publications
    • Webinars
  • About
    • The Clario Story
    • Careers
    • Corporate & Social Responsibility
    • Information Security
    • Leadership
    • Legal & Privacy
    • Newsroom
    • Scientific Expertise
    • Strategic Partnerships
    • Values & Culture
  • Support
    • Customer Support
    • In-Country Cardiac Safety Support
  • Solutions
    • Study Endpoints
      • Cardiac Solutions
        • Cardiac Solutions
        • Arrhythmia Analysis
        • Blood Pressure Services
        • ECG — On-site to DCT and Phase I-IV
        • Phase I/TQT Cardiac Assessment
        • Regulatory Consultation and Statistical Analysis Expertise
      • Clinical Adjudication
      • eCOA
        • eCOA Clinical Trials
        • eCOA Live
        • eCOA Multimedia
        • eCOA Rapid Start
        • eCOA Rater and Participant Training
        • eCOA Rescue Studies
        • Suicidal Ideation
      • Medical Imaging
        • Medical Imaging
        • Image Redact AI
        • Imaging Platform
        • Medical Imaging Science Team
        • Modalities
        • SMART Submit
      • Precision Motion
        • Precision Motion for Clinical Trials
        • Precision Motion for Research
        • Precision Motion: Scientific Publications
      • Respiratory Solutions
        • Respiratory Solutions
        • Site-Based Spirometry
        • Virtual Home Spirometry
        • Cough and Lung Sounds
        • Diffusing Capacity (DLCO)
      • Trial Enablement
        • Trial Enablement
        • Eligibility Solution
        • Reporting & Analytics
        • Source Document Manager
    • Segments
      • Biotechs
      • CROs
      • Pharma
    • Study Phases
      • Phase I
      • Phase II/III
    • Technology
      • Artificial Intelligence (AI)
      • Hybrid Trials
  • Therapeutic Areas
    • Cardiovascular & Metabolic
    • Dermatology
    • Diabetes and Obesity
    • Gastroenterology
    • Hepatology
    • Infectious Diseases
    • Musculoskeletal
    • Neuroscience
      • Headache Disorders
      • Movement Disorders
      • Multiple Sclerosis
      • Pain Disorders
      • Psychiatric Disorders
    • Oncology
    • Ophthalmology
    • Respiratory
  • Resources
    • Blog Articles
    • Case Studies
    • Downloads
    • Events
    • External Publications
    • Webinars
  • About
    • The Clario Story
    • Corporate & Social Responsibility
    • Information Security
    • Leadership
    • Legal & Privacy
    • Scientific Expertise
    • Strategic Partnerships
    • Values & Culture
  • Support
    • Customer Support
    • In-Country Cardiac Safety Support
  • Careers
    • Life at Clario
  • Newsroom
  • Login
  • Contact sales
    • Log in
    • Contact sales
  1. Home Resources Blog Articles World Earth Day: Sharing our sustainability initiatives and joining the UN Global Compact 

World Earth Day: Sharing our sustainability initiatives and joining the UN Global Compact 

Key initiatives in Clario’s sustainability strategy

Otis Johnson, Ph.D., M.P.A. – Chief Diversity, Inclusion, and Sustainability Officer at Clario

Clinical trials save lives, so it’s easy to see the good that Clario’s work does simply in terms of the nature of the industry in which we operate. However, I see a broader responsibility for companies such as Clario. As a leader in our industry, we also need to be a leader in our environmental, social, and corporate governance (ESG) responsibilities. This is why we joined the United Nations (UN) Global Compact as a further step in our commitment to creating a more equitable and sustainable society. 

The UN Compact asks companies to operate in ways that, at a minimum, meet fundamental responsibilities in the areas of human rights, labor, environment, and anti-corruption. You can read more about our announcement and some of our commitments in these areas in our press release and the statement our CEO, Joe Eazor, wrote about joining.  

But as today is World Earth Day, I want to focus specifically on some of the key initiatives we have made in our sustainability strategy. 

Climate action

First and foremost, Clario is working on a plan to reach net-zero emissions. This commitment to reducing the impact of climate change throughout our operations launched in 2020 when we began measuring our greenhouse gas (GHG) emissions and completed a carbon disclosure program (CDP) assessment. This assessment evaluated and scored our overall environmental performance. As part of our commitment to the UN Global Compact, we are working to improve our measurement system to obtain the most accurate data possible and take systemic action to reduce our carbon footprint and GHG emissions. We are also working to have our improvement targets validated by the Science Based Target initiative (SBTi). 

We are also involved in the Save the Planet initiative, which works towards greater environmental protection and corporate responsibility. Additionally, taking part in the Save Energy Project has helped us establish guidelines for reducing personal energy use. 

Responsible consumption and production 

In addition to driving sustainable practices internally, we thoroughly vet our suppliers to ensure our supply chain meets the highest standards at all times. We review key sustainability metrics (e.g., supplier diversity demographics), include environmental sustainability criteria in RFPs, and evaluate suppliers based on their commitment to reducing carbon emissions.  

As a technology company, we are acutely aware of the potential damage electronic waste and the strain production of technology devices can put on environmental resources. This is why we are investing heavily in Bring Your Own Device (BYOD) and multi-protocol devices throughout the organization and during clinical trials. BYOD can have a significant environmental benefit by driving the re-use of devices rather than the purchase of new ones, reducing the amount of packaging needed and an overall reduction in shipping volumes. There is also a patient benefit. Using devices familiar to patients during the already uncertain experience of being in a clinical trial can help with trial protocol compliance and the overall ease of participation. 

BYOD is only one aspect of how we support the re-use of existing equipment. Through our partnerships with U.S.-based Inspiredu and Angestöpselt e.V. out of Germany, we ensure our technology has an extended life by wiping devices clean and donating them to underprivileged youths to help them learn computer skills. Last year, we donated 120 devices to Angestöpselt e.V. and more than 2,000 laptops to Inspiredu. When our technology reaches the end of its life with us, it can help a critically underserved population gain skills for education and career success and improve digital literacy by increasing access to technology. 

Validation

A strategy is only as good as the data used to measure its effectiveness. We use established, recognized standards to monitor our progress. For example, we evaluate our management systems through renowned external assessment platforms, such as EcoVadis, to assess Clario’s sustainability performance and CyberVadis to assess cyber security strength.  

Clario’s inaugural ESG report

We are proud to be a part of the UN Global Compact, which has taken us one step further in holding ourselves accountable for our actions and commitments. We are taking another step toward commitment and accountability with the upcoming release of our inaugural Environmental, Social, and Governance (ESG) report, a public commitment to our actions and plan to take over the next several years. Some key initiatives we will outline in the report include ensuring drug safety through accurate data, providing employment opportunities for all people, and obstructing corruption and bribery.  

World Earth Day calls on us to invest in our planet and be part of the change. These are sentiments I can echo both personally and professionally. I am proud to work for a company that takes them as seriously in its business as I do at home with my family. 

Championing global principles for a better future

Curious about our unwavering commitment to global sustainability and ethical practices? Discover how Clario proudly endorses the United Nations Global Compact and its transformative principles.

Read news
Back to articles
Share
Twitter Facebook LinkedIn

Latest articles

See all articles
Article

Researcher spotlight: Dr. Lauren Tueth

Precision Motion

Read
Article

Researcher spotlight: Brice Cleland

Precision Motion

Read
Article

Researcher spotlight: Josefa Domingos

Precision Motion

Read
Clario logo
    • Solutions
    • Therapeutic Areas
    • About
    • Resources
    • Careers
    • Newsroom
  • Get in touch

    • Contact
    • Support
    • Customer portal

Follow us

Twitter LinkedIn Glassdoor
×

Contact sales

If you are looking for a partner to help you generate the richest clinical evidence with the right clinical trial technology, please fill in the form below.


Not what you're looking for?

Please visit our Contact Page for customer support, office locations, or media contacts.

  • © 2025 Clario

    • Legal and Privacy Terms
    • Information Security
    • Cookie Policy
    • Impressum